Previous studies demonstrate that NF-κB is capable of directly or indirectly activating oncogenic pathways via cytokines, such as IL-6 and IL-1β, in HNSCC [13, 18]. The gene discussed is IL6; the disease is head and neck squamous cell carcinoma.